tiprankstipranks
Trending News
More News >

Theriva Biologics Announces At-The-Market Stock Offering

Story Highlights
  • Theriva Biologics filed a prospectus to sell up to $2.5 million in common stock.
  • The sales will be conducted through A.G.P./Alliance Global Partners as an at-the-market offering.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Theriva Biologics Announces At-The-Market Stock Offering

Don’t Miss TipRanks’ Half-Year Sale

Theriva Biologics ( (TOVX) ) just unveiled an announcement.

On June 20, 2025, Theriva Biologics, Inc. announced the filing of a prospectus supplement related to the offer and sale of up to $2,534,352 of its common stock. This move, facilitated through A.G.P./Alliance Global Partners, aims to raise capital via an at-the-market offering, with the sales agent acting as an underwriter under the Securities Act of 1933.

The most recent analyst rating on (TOVX) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on Theriva Biologics stock, see the TOVX Stock Forecast page.

Spark’s Take on TOVX Stock

According to Spark, TipRanks’ AI Analyst, TOVX is a Neutral.

Theriva Biologics faces substantial financial difficulties with no revenue and growing losses, which is a major concern. While technical indicators show some short-term positive momentum, the long-term trend remains negative. The lack of profitability impacts valuation. However, the recent positive clinical trial results provide a potential future catalyst that could improve the company’s prospects.

To see Spark’s full report on TOVX stock, click here.

More about Theriva Biologics

Theriva Biologics, Inc. operates in the biotechnology industry, focusing on the development and commercialization of biologics. The company is involved in offering innovative therapeutic solutions and has a market focus on advancing its pipeline of biologic candidates.

Average Trading Volume: 1,407,671

Technical Sentiment Signal: Strong Sell

Current Market Cap: $3.69M

Find detailed analytics on TOVX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1